Showing results (1181-1190 of 4,565) with videos related to

Sort By:
Pageof 457
Advances in Therapy|October 6, 2025
A Functional Genetic Score in the ZMIZ1/TGF-β/STAT Pathway Predicts Early Biologic Discontinuation in Psoriasis Patients Treated with Anti-TNF and Anti-IL12/23 AgentsJuan de Luque, Carmen Mochón-Jiménez, Irene Rivera-Ruiz, et al.
Advances in Therapy|September 23, 2025
A Strategic Roadmap to Support Communication on and Acceptance of Surrogate Endpoints: The REnal Surrogacy accEpTance in Chronic Kidney Disease (RESET CKD) CollaborationJuan José Garcia Sanchez, Marta Trapero-Bertran, Oriana Ciani, et al.
Advances in Therapy|September 25, 2025
Real-World Comparative Effectiveness Study in Patients with Asthma Initiating Fluticasone Furoate/Vilanterol or Beclometasone Dipropionate/Formoterol Fumarate in General Practice in EnglandAshley Woodcock, John Blakey, Arnaud Bourdin, et al.
Advances in Therapy|May 27, 2024
Qualitative Study of the Patient Experience with Venglustat for Gaucher Disease Type 3 in a Phase 2 Open-Label, Multicenter, Multinational Study (LEAP)Raphael Schiffmann, Eugen Mengel, Mary Wallace, et al.
Advances in Therapy|December 17, 2020
Efficacy and Safety of Intravitreal Aflibercept Injection in Japanese Patients with Neovascular Glaucoma: Outcomes from the VENERA StudyMasaru Inatani, Tomomi Higashide, Kenji Matsushita, et al.
Advances in Therapy|October 14, 2020
A Narrative Review of the Patient Journey Through the Lens of Non-communicable Diseases in Low- and Middle-Income CountriesRatna Devi, Komal Kanitkar, R Narendhar, et al.
Advances in Therapy|October 14, 2020
Mesothelin Expression in Patients with High-Grade Serous Ovarian Cancer Does Not Predict Clinical Outcome But Correlates with CD11c+ Expression in TumorIsabelle Magalhaes, Josefin Fernebro, Sulaf Abd Own, et al.
Advances in Therapy|October 2, 2020
Clinical Characteristics of a Non-Alcoholic Fatty Liver Disease Population Across the Fibrosis Spectrum Measured by Magnetic Resonance Elastography: Analysis of Screening DataGrit Andersen, Leona Plum-Mörschel, Paul D Hockings, et al.
Advances in Therapy|December 25, 2019
Long-Term, Real-World Safety and Efficacy of Teneligliptin: A Post-Marketing Surveillance of More Than 10,000 Patients with Type 2 Diabetes in JapanTakashi Kadowaki, Masakazu Haneda, Hiroshi Ito, et al.
Advances in Therapy|December 25, 2019
Correction to: Combining GLP-1 Receptor Agonists and Basal Insulin in Older Adults with Type 2 Diabetes: Focus on Lixisenatide and Insulin GlargineYehuda Handelsman, Marcel H A Muskiet, Graydon S Meneilly
Pageof 457